X
X T L Biopharmaceuticals Ltd
TASE:XTLB
X T L Biopharmaceuticals Ltd
TASE:XTLB
Price:
2.3
ILS
Market Closed
Market Cap:
₪21.8m
Balance Sheet
Balance Sheet Decomposition
X T L Biopharmaceuticals Ltd
X T L Biopharmaceuticals Ltd
Balance Sheet Decomposition is not available for
X T L Biopharmaceuticals Ltd
X T L Biopharmaceuticals Ltd
Balance Sheet
X T L Biopharmaceuticals Ltd
X T L Biopharmaceuticals Ltd
Currency: USD
| Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
1
|
1
|
2
|
4
|
2
|
3
|
3
|
|
| Cash |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
2
|
4
|
2
|
3
|
3
|
|
| Short-Term Investments |
0
|
1
|
1
|
2
|
3
|
0
|
0
|
0
|
3
|
5
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
1
|
2
|
4
|
5
|
3
|
4
|
3
|
6
|
8
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
3
|
2
|
5
|
3
|
3
|
1
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
4
+428%
|
4
+7%
|
11
+172%
|
8
-28%
|
6
-30%
|
5
-6%
|
3
-43%
|
7
+118%
|
9
+30%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+35%
|
1
-34%
|
4
+492%
|
2
-53%
|
1
-44%
|
0
-55%
|
0
-25%
|
3
+800%
|
0
-92%
|
|
| Equity | |||||||||||
| Common Stock |
1
|
5
|
5
|
6
|
6
|
6
|
7
|
7
|
13
|
13
|
|
| Retained Earnings |
141
|
142
|
143
|
144
|
146
|
148
|
152
|
155
|
156
|
153
|
|
| Additional Paid In Capital |
140
|
140
|
141
|
147
|
148
|
148
|
151
|
151
|
146
|
148
|
|
| Treasury Stock |
0
|
0
|
0
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
3
+28 200%
|
3
+22%
|
7
+114%
|
6
-15%
|
5
-26%
|
5
+5%
|
3
-45%
|
4
+35%
|
8
+130%
|
|
| Total Liabilities & Equity |
1
N/A
|
4
+428%
|
4
+7%
|
11
+172%
|
8
-28%
|
6
-30%
|
5
-6%
|
3
-43%
|
7
+118%
|
9
+30%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1
|
4
|
408
|
46
|
44
|
47
|
55
|
27
|
51
|
51
|
|
Switch to:
Switch to:
See Also
Discover More
